PATENT CLAIM ANALYSIS

Application Number: 15957951
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-10
Patent Classification: ["514", "04400A"]

Abstract:
Disclosed herein is a method of preventing and/or treating abnormal bone resorption and/or osteoporosis in a subject in need thereof. The method comprises administering to the subject an effective amount of an inhibitor on inhibiting neddylation. According to some embodiments of the present disclosure, the inhibitor on inhibiting neddylation is a NAE inhibitor, which includes but is not limited to, MLN4924.

Claim (Index 6):
The method of  claim 2 , wherein the subject is a human, and the effective amount is about 0.01-100 mg/kg body weigh per day.

Metadata:
- Claim Count in Document: 20.0
- Percentile: 91.0
- Lexical Diversity: 1.55814
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['10734692', '14905298', '14368080', '14234033', '12526311']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.772290588085365
- 35 USC 102 Novelty (BERT): 0.519321219139983
- Combined Prediction Score: 0.7469936511908268
- Mean Citation Score: 242.70882000000003
- Max Citation Score: 257.7636
- Similarity Product: 142.7452685769081

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test